Company intelligence / Profile preview

OnKai

Ownership: Private
Development stage: Other

Overview

OnKai has developed the Smart Grid AI-based solution that connects stakeholders—clinics, pharma companies, foundations—to optimize care pathways and enable equitable participation in clinical research for underserved communities. The company’s impact includes improving representation in clinical trials and addressing health disparities by facilitating real-time data-driven decision-making at safety-net clinics. No direct drug or therapeutic results as the company provides enabling technology rather than therapeutics.

Modalities: Non-pharmacological therapy (AI-powered digital platform)
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Galmed Pharmaceuticals

Beyond the preview

Go deeper on OnKai.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OnKai.

Explore the full profile